Skip to main content
Skip to content
Case File
efta-01735624DOJ Data Set 10Other

EFTA01735624

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01735624
Pages
4
Persons
0
Integrity

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
41) Quest Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client information EPSTEIN, JEFFREY DOB: 01/20/1953 ACE: 63 Gender: M Phone: Patient ID: 19530120MJE Specimen: KP992895A Requisition: 0842795 Collected: 11/11/2016 / 11:20 EST Received: 11/14/2016 / 16:33 EST Reported: 11/18/2016 / 11:38 EST Client #: 78300020 MA1L992 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, BRUCE MD Ann: APAL NATIONWIDE ACT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 SUMMARY OF REPORT CHANGES Please refer to the body of the report(s) for complete information Test Name => REVISED: Change in test result(s) Pin, INTACT AND CALCIUM CALCIUM C-REACTIVE PROTEIN In Range Out Of Range 10.0 Reference Range 8.6-10.3 mg/dL <0.80 mg/dL PLEASE DISREGARD PREVIOUSLY REPORTED INFORMATION BELOW: ORIGINALLY REPORTED ON 11/14/2016 at 5:15 PM EST CALCIUM 8.6-10.3 mg/dL PERFORMING LABORATORY INFORMATION QUEST DIAGNOSTICS ONE MALCOLM AVENUE TETERBORO, NJ. 07608 LABORATORY DIRECTOR: LAWRENCE TSAO, M.D. CLIA NO: 31D0696246 ORIGINALLY REPORTED ON 11/14/2016 at 5:03 PM EST C-REACTIVE PROTEIN <0.80 mg/dL Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PERFORMING LABORATORY INFORMATION QUEST DIAGNOSTICS ONE MALCOLM AVENUE TETERBORO, NJ. 07608 LABORATORY DIRECTOR: LAWRENCE TSAO, M.D. CLIA NO: 31D0696246 CLIENT SERVICES: 866.697.8378 SPECIMEN: KP992895A Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGEIOF4 EFTA_R1_00019751 EFTA01735624 41) Quest Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client information EPSTEIN, JEFFREY DOB: 01/20/1953 ACE: 63 Gender: M Phone: Patient ID: 19530120MJE Specimen: KP992895A Requisition: 0842795 Collected: 11/11/2016 / 11:20 EST Received: 11/14/2016 / 16:33 EST Reported: 11/18/2016 / 11:38 EST Client #: 78300020 MA1L992 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, BRUCE MD Ann: APAL NATIONWIDE ACT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-341 8 Test Name LIPID PANEL CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL In Range Out Of Range Reference Range 221 H 18 L 988 H LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 12.3 H NON HDL CHOLESTEROL 203 H Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. COMPREHENSIVE METABOLIC PANEL GLUCOSE 83 UREA NITROGEN (BUN) 24 CREATININE 0.90 For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE CALCIUM PROTEIN, TOTAL ALBUMIN GLOBULIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL ALKALINE PHOSPHATASE AST ALT PTH, INTACT AND CALCIUM PTH, INTACT PARATHYROID HORMONE, INTACT 91 105 NOT APPLICABLE 139 4.4 102 29 135-146 mmol/L 3.5-5.3 mmol/L 98-110 mmol/L 20-31 mmol/L 10.0 8.6-10.3 mg/dL 7.3 6.1-8.1 g/dL 4.4 3.6-5.1 g/dL 2.9 1.9-3.7 g/dL (calc) 1.5 1.0-2.5 (talc) 0.5 0.2-1.2 mg/dL 68 40-115 U/L 20 10-35 U/L 20 9-46 U/L 0110 106 H 14-64 pg/mL 125-200 mg/dL > OR = 40 mg/dL <150 mg/dL <130 mg/dL (calc) < OR = 5.0 (calc) mg/dL (calc) 65-99 mg/dL Lab QHO QHO OHO QHO 0110 OHO OHO Fasting 7-25 reference interval mg/dL 0.70-1.25 mg/dL > OR = 60 mL/min/1.73m2 > OR = 60 mL/min/1.73m2 6-22 (talc) Interpretive Guide Intact PTH CLIENT SERVICES: 866.697.8378 Calcium SPECIMEN:KP992895A Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks orQuest Diagnostics. PAGE20F4 EFTA_R1_00018752 EFTA01735625 Quest • (i; sv Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client information EPSTEIN, JEFFREY Specimen: KP992895A Client #: 78300020 Collected: 11/I 1/2016 / 11:20 EST MOSKOWITZ, BRUCE W DOB: 01/20/1953 ACE: 63 Received: 11/14/2016 / 16:33 EST Gender: M Reported: 11/18/2016 / 11:38 EST Patient ID: 19530120MJE Test Name Normal Parathyroid Hypoparathyroidism Hyperparathyroidism Primary Secondary Tertiary Non-Parathyroid Hypercalcemia -> CALCIUM In Range Normal Out Of Range Reference Range Normal Low or Low Normal Low Normal or High High High Low or Low Normal High Normal or Low High High 10.0 8.6-10.3 mg/dL PERFORMING LABORATORY INFORMATION QUEST DIAGNOSTICS ONE MALCOLM AVENUE TETERBORO, NJ. 07608 LABORATORY DIRECTOR: LAWRENCE TSAO, M.D. CLIA NO:31D0696246 SED RATE BY MODIFIED WESTERGREN 1 < OR = 20 mm/h VITAMIN B12 517 200-1100 pg/mL =>C-REACTIVE PROTEIN 0.10 <0.80 mg/dL Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PSA, TOTAL 0.5 < OR = 4.0 ng/mL This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. TESTOSTERONE,FR(DIALYSIS) AND TOTAL(LC/MS/MS) TESTOSTERONE, TOTAL, LC/MS/MS 194 250-1100 ng/dL Men with clinically significant hypogonadal symptoms and testosterone values repeatedly in the range of the 200-300 ng/dL or less, may benefit from testosterone treatment after adequate risk and benefits counseling. For more information on this test, go to http://education.questdiagnostics.com/faq/ TotalTestosteroneLCMSMS FREE TESTOSTERONE 44.6 35.0-155.0 pg/mL CLIENT SERVICES: 866.697.8378 SPECIMEN: KP992895A Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks orQuest Diagnostics. Lab OHO QHO QHO QHO QHO AMD PAG830F4 EFTA_R1_00019753 EFTA01735626 (0) Quest -• Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 ACE: 63 Gender: M Patient ID: 19530120MJE Specimen: KP992895A Collected: 11/11/2016 / 11:20 EST Received: 11/14/2016 / 16:33 EST Reported: 11/18/2016 / 11:38 EST Client #: 78300020 MOSKOWITZ, BRUCE W Result Reference Range 43 30-100 ng/mL Lab OHO Endocrinology Test Name VITAMIN D,25-OH,TOTALJA Vitamin D Status 25-0H Vitamin D: Deficiency: <20 ng/mL Insufficiency: 20 - 29 ng/mL Optimal: > or 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-0H VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: http://education.questdiagnostics.com/faq/FA0163 (This link is being provided for informational/educational purposes only.) Physician Comments: PERFORMING SITE: ALM QUEST D1AGNOSTICSNICHOIS CHANTILLY. 14225 NEWBROOK DRIVE• CHANTILLY, NA 20131.2221Iaconory INttoor PATRICK W. MASONMIDEHIL CIA*. 49142221201 LINO QUEST DLAGNOSTICS HORSHAM. 900 BUSINESS CENTER DRIVE. HORSHA.M. PA 19011-3432 Labotasory DInoor. ANDREW S EDELMAN. MD PEID.CLIA: 390020141M CLIENT SERVICES: 866.697.8378 SPECIMEN: KP992895A PAGE 4 OF 4 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks orQuest Diagnostics. EFTA_R1_00019754 EFTA01735627

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.